Real-World Evidence in Drug Development and Evaluation

Discover the transformative power of real-world data in the pharmaceutical landscape with Real-World Evidence in Drug Development and Evaluation by Taylor & Francis Ltd. Published in 2022, this insightful paperback spans 178 pages, offering a comprehensive exploration of how real-world data (RWD) and real-world evidence (RWE) can significantly enhance drug development throughout the product lifecycle.

Unlike traditional controlled randomized trials (CRTs), RWD encompasses healthcare information gathered in real-world settings, providing a richer context for understanding treatment outcomes. This book delves into the aggregation and analysis of RWD, revealing how RWE can inform decision-making and optimize drug evaluation processes.

Perfect for professionals in the pharmaceutical industry, researchers, and students, this essential resource will equip you with the knowledge to navigate the evolving landscape of drug development and evaluation. Enhance your understanding and stay ahead in the field with this crucial read.